Reduced immunogenicity of MYC amplified, metastatic prostate cancer
MYC amplification is associated with reduced tumor immunogenicity as assessed by the recovery of IR recombination reads from prostate cancer genomics files.
Authors
- Taha I. Huda (ORCID: https://orcid.org/0000-0002-2760-7078)
- George Blanck (ORCID: https://orcid.org/0000-0003-1664-0996)
- Mallika Varkhedi
- Vayda R. Barker (ORCID: https://orcid.org/0000-0003-4452-8926)
- Sunny Kahlon
- Alex Wang
Institutions
- University of Tennessee Health Science Center (US)
- Center for Cancer Research (US)
Publication Details
- Journal
- Oncoscience
- Published
- 2025-12-30
- DOI
- https://doi.org/10.18632/oncoscience.644
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00